TherapeuticsMD (TXMD) EBT Margin (2011 - 2026)
TherapeuticsMD (TXMD) reported EBT Margin of 14.23% for Q1 2026, up 18420.0% on a YoY basis from N/an in Q1 2025, and up 121.9% quarter-over-quarter from 64.95% in Q4 2025.
TherapeuticsMD (TXMD) EBT Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD has reported EBT Margin for 16 years, with the latest figure at 14.23% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 18420.0% year-over-year to 14.23%; the trailing twelve-month figure through Mar 2026 stood at 3.52% (up 12313.0% YoY), and the FY2025 full-year result was 21.61%, up 11144.0% from the prior year.
- EBT Margin for Q1 2026 stood at 14.23%, up from 64.95% in the prior quarter.
- The five-year high for EBT Margin was 70.67% in Q4 2022, with the low at 4273.85% in Q2 2022.
- Historically, EBT Margin has averaged 940.74% across 5 years, with a median of 258.47% in 2024.
- Annual changes were most pronounced in 2022 — EBT Margin plunged 408842 bps — and 2023, when it surged 372145 bps.
- TherapeuticsMD's EBT Margin stood at 70.67% in 2022, then sank by 547 bps to 315.54% in 2023, then soared by 104 bps to 12.44% in 2024, then sank by 622 bps to 64.95% in 2025, then surged by 122 bps to 14.23% in 2026.
- The last three EBT Margin figures came in at 14.23% (Q1 2026), 64.95% (Q4 2025), and 6.38% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | 14.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.23% |
| Dec 31, 2025 | -64.95% |
| Sep 30, 2025 | 6.38% |
| Jun 30, 2025 | 57.25% |
| Mar 31, 2025 | -169.97% |
| Dec 31, 2024 | 12.44% |
| Sep 30, 2024 | -103.66% |
| Jun 30, 2024 | -448.72% |
| Mar 31, 2024 | -258.47% |
| Dec 31, 2023 | -315.54% |
| Sep 30, 2023 | -2,705.66% |
| Jun 30, 2023 | -552.40% |
| Mar 31, 2023 | -555.29% |
| Dec 31, 2022 | 70.67% |
| Sep 30, 2022 | -4,133.05% |
| Jun 30, 2022 | -4,273.85% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | 268.50% |
| Sep 30, 2021 | -186.65% |
| Jun 30, 2021 | -185.44% |